Parotidectomy for benign parotid disease at a university teaching hospital: Outcome of 963 operations

Laryngoscope

Volumn 116, Issue 4, 2006, Pages 534-540

  Guntinas Lichius, Orlando ^a   Klussmann, J Peter ^a   Wittekindt, Claus ^a   Stennert, Eberhard ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Complications; Facial nerve; Head and neck surgery; Parotidectomy; Surgical education

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER RECURRENCE; CHILD; CLINICAL PRACTICE; COMPETENCE; CONTROLLED STUDY; FACIAL NERVE PARALYSIS; FEMALE; FREY SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MUSCLE WEAKNESS; OPERATION DURATION; OUTCOME ASSESSMENT; PAROTID GLAND TUMOR; PAROTIDECTOMY; PAROTITIS; PERIOPERATIVE PERIOD; PLEOMORPHIC ADENOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKILL; SURGEON; SURGICAL TRAINING; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; WARTHIN TUMOR; CLINICAL COMPETENCE; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; ORAL SURGERY; PAROTID GLAND; PAROTID GLAND DISEASE; RECURRENT DISEASE; STANDARD; STATISTICS; TIME; TREATMENT OUTCOME;

CLINICAL COMPETENCE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; ORAL SURGICAL PROCEDURES; PAROTID DISEASES; PAROTID GLAND; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645926337     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000200741.37460.ea     Document Type: Article

References (23)

1. Marshall AH, Quraishi SM, Bradley PJ. Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol 2003;117:624-629.
2. Woods JE. Parotidectomy versus limited resection for benign parotid masses. Am J Surg 1985;149:749-750.
3. Guntinas-Lichius O, Kick C, Klussmann JP, Jungehuelsing M, Stennert E. Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur Arch Otorhinolaryngol 2004;261:143-146.
4. Helmus C. Subtotal parotidectomy: a 10-year review (1985 to 1994). Laryngoscope 1997;107:1024-1027.
5. McGurk M, Thomas BL, Renehan AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer 2003;89:1610-1613.
6. Witt RL. Facial nerve function after partial superficial parotidectomy: an 11-year review (1987-1997). Otolaryngol Head Neck Surg 1999;121:210-213.
7. Piekarski J, Nejc D, Szymczak W, Wronski K, Jeziorski A. Results of extracapsular dissection of pleomorphic adenoma of parotid gland. J Oral Maxillofac Surg 2004;62:1198-1202.
8. Carr MM. Program directors' opinions about surgical competency in otolaryngology residents. Laryngoscope 2005;115:1208-1211.
9. O'Brien CJ, Murrant NJ. Surgical management of chronic parotitis. Head Neck 1993;15:445-449.
10. Sittel C, Stennert E. Prognostic value of electromyography in acute peripheral facial nerve palsy. Otol Neurotol 2001;22:100-104.
11. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweiβabsonderung. Dt Z Nervenheilk 1928;101:302-309.
12. Dulguerov P, Marchal F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope 1999;109:754-762.
13. Makeieff M, Venail F, Cartier C, Garrel R, Crampette L, Guerrier B. Continuous facial nerve monitoring during pleomorphic adenoma recurrence surgery. Laryngoscope 2005;115:1310-1314.
14. Gaillard C, Perie S, Susini B, St Guily JL. Facial nerve dysfunction after parotidectomy: the role of local factors. Laryngoscope 2005;115:287-291.
15. Glas AS, Vermey A, Hollema H, et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients. Head Neck 2001;23:311-316.
16. Witt RL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 2002;112:2141-2154.
17. O'Brien CJ, Malka VB, Mijailovic M. Evaluation of 242 consecutive parotidectomies performed for benign and malignant disease. Aust N Z J Surg 1993;63:870-877.
18. Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Menard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-1494.
19. McGurk M, Renehan A, Gleave EN, Hancock BD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg 1996;83:1747-1749.
20. Witt RL. Facial nerve function after partial superficial parotidectomy: an 11-year review (1987-1997). Otolaryngol Head Neck Surg 1999;121:210-213.
21. Mehle ME, Kraus DH, Wood BG, et al. Facial nerve morbidity following parotid surgery for benign disease: the Cleveland Clinic Foundation experience. Laryngoscope 1993;103:386-388.
22. Leverstein H, van der Waal JE, Tiwari RM, van dW I, Snow GB. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 1997;84:399-403.
23. Wennmo C, Spandow O, Emgard P, Krouthen B. Pleomorphic adenomas of the parotid gland: superficial parotidectomy or limited excision? J Laryngol Otol 1988;102:603-605.